This notion is in line with the finding that Fgf21 serum levels are often elevated in obesity-associated IR (Fisher and Maratos-Flier, 2016; Morrice et al., 2017), possibly reflecting resistance to Fgf21 (Fisher et al., 2010). The gene discussed is FGF21; the disease is obesity disorder.